Dr Reddy’s Laboratories receives two observations for Andhra Pradesh facility

New Delhi: Drug major Dr Reddy’s Laboratories has received a Form 483 with two observations from the US Food and Drug Administration (USFDA) following an inspection at its manufacturing facility in Pydibhimavaram, Andhra Pradesh. The US health regulator completed a Pre-Approval Inspection (PAI) at the company's FTO-11 manufacturing unit from October 5-7, Dr Reddy's Laboratories said in a regulatory filing on Thursday.

Summarised by Agaah from ET Industry. Agaah aggregates 36 sources and removes duplicate coverage — all news, one place.